Filings For: Protagonist Therapeutics, Inc
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Protagonist Therapeutics, Inc (PTGX) 11/6/2026 8:51:50 AM Mid View Financials 10-Q SEC 3Q 2026 ending: 9/30/2026 Rev: $274,410,000 +5,723.6% Assets $1,146,551,000 EPS $3.07
Protagonist Therapeutics, Inc (PTGX) 11/5/2026 4:39:58 PM   View Financials Earnings SEC 3Q 2026 Rev $274,410,000 +5,723.6% Assets $1,146,551,000 EPS $3.07 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/5/2026 4:35:20 PM   View Financials Earnings SEC 2Q 2026 Rev $213,475,000 +3,749.2% Assets $885,544,000 EPS $2.29 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/5/2026 4:25:17 PM Mid View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Rev: $213,475,000 +3,749.2% Assets $885,544,000 EPS $2.29
Protagonist Therapeutics, Inc (PTGX) 5/5/2026 4:33:24 PM Small View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Rev: $56,368,000 +99.0% Assets $697,459,000 EPS $0.05
Protagonist Therapeutics, Inc (PTGX) 5/5/2026 4:11:44 PM   View Financials Earnings SEC 1Q 2026 Rev $56,368,000 +99.0% Assets $697,459,000 EPS $0.05 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/28/2026 4:53:36 PM   View Proxy SEC Y 2025
Protagonist Therapeutics, Inc (PTGX) 2/25/2026 4:34:48 PM Small View Financials 10-K SEC Y 2025 ending: 12/31/2025 Rev: $46,016,000 -89.4% Assets $668,188,000 EPS -$2.05
Protagonist Therapeutics, Inc (PTGX) 2/25/2026 4:15:12 PM   View Financials Earnings SEC Y 2025 Rev $7,437,000 -95.6% Assets $668,188,000 EPS -$0.70 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/6/2025 5:05:59 PM Small View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Rev: $4,712,000 +0.8% Assets $701,688,000 EPS -$0.62
Protagonist Therapeutics, Inc (PTGX) 11/6/2025 4:33:59 PM   View Financials Earnings SEC 3Q 2025 Rev $4,712,000 +0.8% Assets $701,688,000 EPS -$0.62 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/6/2025 4:34:13 PM Small View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Rev: $5,546,000 +33.1% Assets $718,006,000 EPS -$0.55
Protagonist Therapeutics, Inc (PTGX) 8/6/2025 4:14:31 PM   View Financials Earnings SEC 2Q 2025 Rev $5,546,000 +33.1% Assets $718,006,000 EPS -$0.55 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/6/2025 5:13:12 PM Small View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Rev: $28,321,000 -88.9% Assets $742,132,000 EPS -$0.19
Protagonist Therapeutics, Inc (PTGX) 5/6/2025 4:38:44 PM   View Financials Earnings SEC 1Q 2025 Rev $28,321,000 -88.9% Assets $742,132,000 EPS -$0.19 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/29/2025 4:08:33 PM   View Proxy SEC Y 2024
Protagonist Therapeutics, Inc (PTGX) 2/21/2025 4:44:37 PM Small View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $434,433,000 +624.1% Assets $744,725,000 EPS $4.23
Protagonist Therapeutics, Inc (PTGX) 2/21/2025 7:08:12 AM   View Financials Earnings SEC Y 2024 Rev $170,638,000 +184.4% Assets $744,725,000 EPS $2.01 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/7/2024 5:00:14 PM Small View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Rev: $4,675,000 Assets $603,857,000 EPS -$0.54
Protagonist Therapeutics, Inc (PTGX) 11/7/2024 4:16:06 PM   View Financials Earnings SEC 3Q 2024 Rev $4,675,000 Assets $603,857,000 EPS -$0.54 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/6/2024 4:29:41 PM Small View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Rev: $4,167,000 Assets $614,629,000 EPS -$0.50
Protagonist Therapeutics, Inc (PTGX) 8/6/2024 7:10:12 AM   View Financials Earnings SEC 2Q 2024 Rev $4,167,000 Assets $614,629,000 EPS -$0.50 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/7/2024 5:05:41 PM Small View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $254,953,000 Assets $629,276,000 EPS $3.26
Protagonist Therapeutics, Inc (PTGX) 5/7/2024 4:31:18 PM   View Financials Earnings SEC 1Q 2024 Rev $254,953,000 Assets $629,276,000 EPS $3.26 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/26/2024 5:02:03 PM   View Proxy SEC Y 2023
Protagonist Therapeutics, Inc (PTGX) 2/27/2024 4:45:36 PM Small View Financials 10-K SEC Y 2023 ending: 12/31/2023 Rev: $60,000,000 +125.7% Assets $357,951,000 EPS -$1.39
Protagonist Therapeutics, Inc (PTGX) 2/27/2024 4:16:54 PM   View Financials Earnings SEC Y 2023 Rev $60,000,000 Assets $357,951,000 EPS $0.52 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/2/2023 5:19:04 PM Small View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Assets $330,016,000 EPS -$0.58
Protagonist Therapeutics, Inc (PTGX) 11/2/2023 4:42:35 PM   View Financials Earnings SEC 3Q 2023 Rev $0 Assets $330,016,000 EPS -$0.58 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/3/2023 4:40:10 PM Small View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Assets $320,466,000 EPS -$0.68
Protagonist Therapeutics, Inc (PTGX) 8/3/2023 4:26:06 PM   View Financials Earnings SEC 2Q 2023 Rev $0 Assets $320,466,000 EPS -$0.68 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/4/2023 4:54:21 PM Small View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Assets $239,858,000 EPS -$0.67
Protagonist Therapeutics, Inc (PTGX) 5/4/2023 4:32:58 PM   View Financials Earnings SEC 1Q 2023 Rev $0 Assets $239,858,000 EPS -$0.67 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/12/2023 4:03:45 PM   View Proxy SEC Y 2022
Protagonist Therapeutics, Inc (PTGX) 3/15/2023 4:59:43 PM Small View Financials 10-K SEC Y 2022 ending: 12/31/2022 Rev: $26,581,000 -2.8% Assets $247,928,000 EPS -$2.60
Protagonist Therapeutics, Inc (PTGX) 3/15/2023 4:12:44 PM   View Financials Earnings SEC Y 2022 Rev $0 Assets $247,928,000 EPS -$0.70 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/8/2022 5:07:46 PM Small View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Assets $282,174,000 EPS -$0.64
Protagonist Therapeutics, Inc (PTGX) 11/8/2022 4:16:40 PM   View Financials Earnings SEC 3Q 2022 Rev $0 Assets $282,174,000 EPS -$0.64 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/4/2022 5:09:43 PM Small View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Rev: $859,000 -62.1% Assets $310,512,000 EPS -$0.84
Protagonist Therapeutics, Inc (PTGX) 8/4/2022 4:06:17 PM   View Financials Earnings WIRE 2Q 2022 Rev $859,000 -62.1% Assets $310,512,000 EPS -$0.84 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/7/2022 9:40:56 AM Small View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Rev: $25,722,000 +315.6% Assets $348,296,000 EPS -$0.43
Protagonist Therapeutics, Inc (PTGX) 5/4/2022 5:32:23 PM   View Financials Earnings SEC 1Q 2022 Rev $25,722,000 +315.6% Assets $348,296,000 EPS -$0.43 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/13/2022 5:08:47 PM   View Proxy SEC Y 2021
Protagonist Therapeutics, Inc (PTGX) 2/28/2022 6:34:28 PM Small View Financials 10-K SEC Y 2021 ending: 12/31/2021 Rev: $27,357,000 -4.4% Assets $347,695,000 EPS -$2.71
Protagonist Therapeutics, Inc (PTGX) 2/28/2022 4:57:50 PM   View Financials Earnings SEC Y 2021 Rev $8,617,000 +52.5% Assets $347,695,000 EPS -$0.77 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/3/2021 5:22:10 PM Small View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Rev: $10,286,000 -21.6% Assets $373,175,000 EPS -$0.70
Protagonist Therapeutics, Inc (PTGX) 11/3/2021 4:14:46 PM   View Financials Earnings SEC 3Q 2021 Rev $10,286,000 -21.6% Assets $373,175,000 EPS -$0.70 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/4/2021 4:54:31 PM Small View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Rev: $2,265,000 -63.6% Assets $404,232,000 EPS -$0.69
Protagonist Therapeutics, Inc (PTGX) 8/4/2021 4:18:08 PM   View Financials Earnings SEC 2Q 2021 Rev $2,265,000 -63.6% Assets $404,232,000 EPS -$0.69 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/4/2021 5:02:45 PM Small View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Rev: $6,189,000 +69.7% Assets $298,072,000 EPS -$0.54
Protagonist Therapeutics, Inc (PTGX) 5/4/2021 4:09:43 PM   View Financials Earnings SEC 1Q 2021 Rev $6,189,000 +69.7% Assets $298,072,000 EPS -$0.54 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/14/2021 4:11:02 PM   View Proxy SEC Y 2020
Protagonist Therapeutics, Inc (PTGX) 3/10/2021 4:42:20 PM Small View Financials 10-K SEC Y 2020 ending: 12/31/2020 Rev: $28,628,000 +12,293.1% Assets $324,468,000 EPS -$1.92
Protagonist Therapeutics, Inc (PTGX) 3/10/2021 4:09:34 PM   View Financials Earnings SEC Y 2020 Rev $5,650,000 +107.8% Assets $324,468,000 EPS -$0.47 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/4/2020 5:35:07 PM Small View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Rev: $13,114,000 +216.7% Assets $217,320,000 EPS -$0.21
Protagonist Therapeutics, Inc (PTGX) 11/4/2020 5:14:38 PM   View Financials Earnings SEC 3Q 2020 Rev $13,114,000 +216.7% Assets $217,320,000 EPS -$0.21 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/6/2020 4:52:53 PM Small View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Rev: $6,217,000 Assets $224,980,000 EPS -$0.59
Protagonist Therapeutics, Inc (PTGX) 8/6/2020 4:09:49 PM   View Financials Earnings SEC 2Q 2020 Rev $6,217,000 Assets $224,980,000 EPS -$0.59 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/7/2020 5:24:30 PM Micro View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020 Rev: $3,647,000 +133.8% Assets $134,901,000 EPS -$0.72
Protagonist Therapeutics, Inc (PTGX) 5/7/2020 4:40:12 PM   View Financials Earnings SEC 1Q 2020 Rev $3,647,000 +133.8% Assets $134,901,000 EPS -$0.72 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/16/2020 5:29:34 PM   View Proxy SEC Y 2019
Protagonist Therapeutics, Inc (PTGX) 3/10/2020 5:23:17 PM Small View Financials 10-K SEC Y 2019 ending: 12/31/2019 Rev: $231,000 -99.3% Assets $154,917,000 EPS -$2.98
Protagonist Therapeutics, Inc (PTGX) 3/10/2020 4:06:32 PM   View Financials Earnings SEC Y 2019 Rev $2,719,000 +15.6% Assets $154,917,000 EPS -$0.63 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/6/2019 5:35:07 PM Small View Financials 10-Q SEC 3Q 2019 ending: 9/30/2019 Rev: $4,141,000 -32.3% Assets $154,627,000 EPS -$0.61
Protagonist Therapeutics, Inc (PTGX) 11/6/2019 4:40:26 PM   View Financials Earnings SEC 3Q 2019 Rev $4,141,000 -32.3% Assets $154,627,000 EPS -$0.61 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/7/2019 5:34:12 PM Small View Financials 10-Q SEC 2Q 2019 ending: 6/30/2019 Assets $148,105,000 EPS -$1.18
Protagonist Therapeutics, Inc (PTGX) 8/7/2019 9:30:32 AM   View Financials Earnings SEC 2Q 2019 Rev ($8,189,000) Assets $148,105,000 EPS -$1.18 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/8/2019 4:47:49 PM Micro View Financials 10-Q SEC 1Q 2019 ending: 3/31/2019 Rev: $1,560,000 -85.5% Assets $132,248,000 EPS -$0.58
Protagonist Therapeutics, Inc (PTGX) 5/8/2019 7:09:48 AM   View Financials Earnings SEC 1Q 2019 Rev $1,560,000 -85.5% Assets $132,248,000 EPS -$0.58 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/26/2019 5:26:47 PM   View Proxy SEC Y 2018
Protagonist Therapeutics, Inc (PTGX) 3/12/2019 5:13:58 PM Micro View Financials 10-K SEC Y 2018 ending: 12/31/2018 Rev: $30,925,000 +54.1% Assets $139,472,000 EPS -$1.74
Protagonist Therapeutics, Inc (PTGX) 3/12/2019 4:09:33 PM   View Financials Earnings SEC Y 2018 Rev $2,353,000 -79.1% Assets $139,472,000 EPS -$0.57 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/6/2018 5:03:37 PM Small View Financials 10-Q SEC 3Q 2018 ending: 9/30/2018 Rev: $6,117,000 -30.3% Assets $148,856,000 EPS -$0.38
Protagonist Therapeutics, Inc (PTGX) 11/6/2018 4:33:54 PM   View Financials Earnings SEC 3Q 2018 Rev $6,117,000 -30.3% Assets $148,856,000 EPS -$0.38 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/7/2018 5:36:50 PM Micro View Financials 10-Q SEC 2Q 2018 ending: 6/30/2018 Rev: $11,674,000 Assets $137,473,000 EPS -$0.41
Protagonist Therapeutics, Inc (PTGX) 5/9/2018 5:05:15 PM Small View Financials 10-Q SEC 1Q 2018 ending: 3/31/2018 Rev: $10,781,000 Assets $149,239,000 EPS -$0.36
Protagonist Therapeutics, Inc (PTGX) 5/9/2018 4:29:17 PM   View Financials Earnings SEC 1Q 2018 Rev $10,781,000 Assets $149,239,000 EPS -$0.36 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/18/2018 4:06:38 PM   View Proxy SEC Y 2017
Protagonist Therapeutics, Inc (PTGX) 3/7/2018 4:57:30 PM Small View Financials 10-K SEC Y 2017 ending: 12/31/2017 Rev: $20,063,000 Assets $163,734,000 EPS -$2.09
Protagonist Therapeutics, Inc (PTGX) 3/7/2018 4:09:46 PM   View Financials Earnings SEC Y 2017 Rev $11,282,000 Assets $163,734,000 EPS -$0.15 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/7/2017 6:13:51 AM Micro View Financials 10-Q SEC 3Q 2017 ending: 9/30/2017 Rev: $8,781,000 Assets $110,415,000 EPS -$0.29
Protagonist Therapeutics, Inc (PTGX) 11/6/2017 4:02:15 PM   View Financials Earnings SEC 3Q 2017 Rev $8,781,000 Assets $110,415,000 EPS -$0.29 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 8/8/2017 4:53:24 PM Micro View Financials 10-Q SEC 2Q 2017 ending: 6/30/2017 Assets $70,479,000 EPS -$0.89
Protagonist Therapeutics, Inc (PTGX) 8/8/2017 4:23:28 PM   View Financials Earnings SEC 2Q 2017 Assets $70,479,000 EPS -$0.89 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 5/10/2017 4:23:17 PM Micro View Financials 10-Q SEC 1Q 2017 ending: 3/31/2017 Assets $82,673,000 EPS -$0.84
Protagonist Therapeutics, Inc (PTGX) 5/10/2017 4:07:33 PM   View Financials Earnings SEC 1Q 2017 Assets $82,673,000 EPS -$0.84 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 4/24/2017 4:30:58 PM   View Proxy SEC Y 2016
Protagonist Therapeutics, Inc (PTGX) 3/7/2017 4:51:08 PM Micro View Financials 10-K SEC Y 2016 ending: 12/31/2016 Assets $93,990,000 EPS -$5.80
Protagonist Therapeutics, Inc (PTGX) 3/7/2017 4:34:56 PM   View Financials Earnings SEC Y 2016 Assets $93,990,000 EPS -$0.67 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 11/14/2016 5:39:56 PM Micro View Financials 10-Q SEC 3Q 2016 ending: 9/30/2016 Assets $102,843,000 EPS -$0.87
Protagonist Therapeutics, Inc (PTGX) 11/14/2016 5:33:48 PM   View Financials Earnings SEC 3Q 2016 Rev $0 Assets $102,843,000 EPS -$0.87 Export Earnings Model
Protagonist Therapeutics, Inc (PTGX) 9/15/2016 4:08:01 PM Micro View Financials 10-Q SEC 2Q 2016 ending: 6/30/2016 Rev: $27,000 Assets $24,516,000 EPS -$19.07